FT

Fulcrum Therapeutics

FULC

NASDAQHealth Care

Income Statement

Total Revenue$80M

Gross Profit$80M

Operating Income$-21.9M

EBITDA$-8.13M

EBIT$-9.73M

Pre-tax Income$-73.79M

Net Income$-9.73M

Balance Sheet

Cash Equivalent$65.58M

Total Debt$9.39M

Book Value$246.93M

Book Value Per Share4.11

Key Ratios

Return on Equity (ROE)-4.00%

Return on Assets (ROA)-3.73%

Return on Invested Capital (ROI)-4.00%

Net Profit Margin-12.16%

Current Ratio22.63

Quick Ratio22.13

Long-Term Debt / Equitynull